Human Metabolome TechnologiesHuman Metabolome Technologies, Inc.6090東証スタンダードサービス業FY ending Jun 2026, consolidated, J-GAAP

Human Metabolome Technologies revenue and profit

Out of every ¥100 of sales, about ¥15 is left as operating profit. Revenue changed -2.3% from the prior year, operating profit -15.9%.

Five-year trend

Revenue¥1.42B
FY ending Jun 2022: ¥1.22B¥1.22BFY ending Jun 2023: ¥1.3B¥1.3BFY ending Jun 2024: ¥1.35B¥1.35BFY ending Jun 2025: ¥1.46B¥1.46BFY ending Jun 2026: ¥1.42B¥1.42BFY22FY23FY24FY25FY26
Operating income¥209.9M
FY ending Jun 2022: ¥191.2M¥191.2MFY ending Jun 2023: ¥211M¥211MFY ending Jun 2024: ¥220.2M¥220.2MFY ending Jun 2025: ¥249.5M¥249.5MFY ending Jun 2026: ¥209.9M¥209.9MFY22FY23FY24FY25FY26
Operating margin14.8%
FY ending Jun 2022: 15.6%15.6%FY ending Jun 2023: 16.2%16.2%FY ending Jun 2024: 16.4%16.4%FY ending Jun 2025: 17.1%17.1%FY ending Jun 2026: 14.8%14.8%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin14.1%
Asset turnover0.61×
ROA8.6%
ROA8.6%
Financial leverage1.24×
ROE10.7%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin14.1%
2022: 21.9%21.9%2023: 22.0%22.0%2024: 18.1%18.1%2025: 17.6%17.6%2026: 14.1%14.1%2223242526
Asset turnover0.61×
2022: 0.59×0.59×2023: 0.60×0.60×2024: 0.55×0.55×2025: 0.58×0.58×2026: 0.61×0.61×2223242526
ROA8.6%
2022: 12.9%12.9%2023: 13.1%13.1%2024: 9.9%9.9%2025: 10.3%10.3%2026: 8.6%8.6%2223242526
Financial leverage1.24×
2022: 1.45×1.45×2023: 1.38×1.38×2024: 1.35×1.35×2025: 1.30×1.30×2026: 1.24×1.24×2223242526
ROE10.7%
2022: 18.7%18.7%2023: 18.1%18.1%2024: 13.4%13.4%2025: 13.4%13.4%2026: 10.7%10.7%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
202221.9%0.59×12.9%1.45×18.7%
202322.0%0.60×13.1%1.38×18.1%
202418.1%0.55×9.9%1.35×13.4%
202517.6%0.58×10.3%1.30×13.4%
202614.1%0.61×8.6%1.24×10.7%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue18.6%
2021: 11.3%11.3%2022: 19.9%19.9%2023: 20.9%20.9%2024: 24.7%24.7%2025: 19.6%19.6%2026: 18.6%18.6%212223242526
PPE ÷ total assets11.6%
2021: 7.8%7.8%2022: 11.8%11.8%2023: 11.8%11.8%2024: 12.7%12.7%2025: 12.0%12.0%2026: 11.6%11.6%212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥125.1M
2021: ¥98.2M¥98.2M2022: ¥158.3M¥158.3M2023: ¥185.6M¥185.6M2024: ¥181.5M¥181.5M2025: ¥177.1M¥177.1M2026: ¥125.1M¥125.1M212223242526
R&D / revenue8.8%
2021: 8.7%8.7%2022: 12.9%12.9%2023: 14.3%14.3%2024: 13.5%13.5%2025: 12.2%12.2%2026: 8.8%8.8%212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Jun 2022FY ending Jun 2023FY ending Jun 2024FY ending Jun 2025FY ending Jun 2026
Revenue1,2231,2991,3461,4551,422
Cost of revenue383439476533553
Gross profit840860869922869
SG&A649649649672659
Operating income191211220250210
Pretax income262237262270225
Income tax-6-49191324
Net income attributable to owners268286243256200
Operating margin15.6%16.2%16.4%17.1%14.8%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 63%
Property, plant and equipment 12%
2%
2%
Other assets 21%

Funding

Other liabilities 20%
Equity 80%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Jun 2022FY ending Jun 2023FY ending Jun 2024FY ending Jun 2025FY ending Jun 2026
Cash and equivalents¥1.5B¥1.66B¥1.79B¥1.59B¥1.44B
Total assets¥2.07B¥2.29B¥2.6B¥2.37B¥2.28B
Net assets¥1.49B¥1.77B¥1.95B¥1.91B¥1.83B
Share capital¥1.48B¥1.48B¥1.49B¥1.49B¥1.49B
Property, plant and equipment¥243.1M¥270.9M¥331.9M¥285M¥264.4M
Intangible assets excluding goodwill¥6.1M¥21.8M¥17.5M¥12.8M¥33.3M
Investment securities¥7M¥7M¥7M¥50M¥50M
Current assets¥1.74B¥1.85B¥2.1B¥1.86B¥1.77B
Current liabilities¥546.3M¥493M¥632.8M¥449.9M¥438.8M
Short-term borrowings¥200M¥200M¥200M¥100M¥100M
Total liabilities¥582.2M¥518.7M¥656.7M¥466M¥451.4M
Equity attributable to owners of parent¥1.43B¥1.72B¥1.91B¥1.91B¥1.85B
Retained earnings-¥1.52B¥233.1M¥417.3M¥585M¥699.9M
Treasury stock-¥143K-¥167K-¥167K-¥166.6M-¥350.2M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第23期(2025/07/01-2026/06/30)

    ID S100Z2EI2026-09-17Open
  • EDINET (FSA Japan)

    有価証券報告書-第22期(2024/07/01-2025/06/30)

    ID S100WPSX2025-09-22Open
  • EDINET (FSA Japan)

    有価証券報告書-第21期(2023/07/01-2024/06/30)

    ID S100UE9D2024-09-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第20期(2022/07/01-2023/06/30)

    ID S100RW1Z2023-09-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第19期(令和3年7月1日-令和4年6月30日)

    ID S100P8152022-09-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第18期(令和2年7月1日-令和3年6月30日)

    ID S100MHKD2021-09-27Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.